Wholesale of pharmaceutical and medical goods
FYSIOLINE NORWAY AS
Revenue 2025
NOK 5.7m
Operating profit
NOK −675,000
Equity
NOK −6.9m
Incorporated
2022
Share capital
NOK 30,000
Key figures · 2025
Current ratio
3.15
Equity ratio
-257.7%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -11.8% | |
| Net margin (%%) | -12.6% | |
| Return on assets (%%) | -25.1% | |
| Likviditet | ||
| Current ratio | 3.15 | |
| Working capital | 1.8m | |
| Soliditet | ||
| Equity ratio (%%) | -257.7% | |
| Debt-to-equity ratio | -1.39 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.